Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ANVS · NYSE · Pharmaceutical Preparations
$0.7113−0.0371 (−4.96%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Annovis Bio (ANVS) · oqro.io/stocks/ANVS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 6, 2026 · Filed Nov 6, 2026
Director purchased ~$5M of ANVS shares in the open marketSource5%+ stake · Stake as of Sep 30, 2026 · Filed Oct 15, 2026
Empery Asset Management, LP cut its ANVS stake below 5% (5.0%)SourceInsider trade · Traded May 20, 2026 · Filed May 22, 2026
Director purchased ~$104K of ANVS shares in the open marketSourceInsider trade · Traded May 20, 2026 · Filed May 22, 2026
Director purchased ~$34K of ANVS shares in the open marketSourceInsider trade · Traded May 20, 2026 · Filed May 22, 2026
Director purchased ~$4.5K of ANVS shares in the open marketSourceInsider trade · Traded Apr 2, 2026 · Filed Apr 3, 2026
Director purchased ~$1.5M of ANVS shares in the open marketSourceInsider trade · Traded Dec 8, 2025 · Filed Dec 9, 2025
Director purchased ~$130K of ANVS shares in the open marketSourceInsider trade · Traded Dec 8, 2025 · Filed Dec 9, 2025
Director purchased ~$64K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$117K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$117K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$35K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$35K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$6.1K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$1.7K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$6.1K of ANVS shares in the open marketSourceInsider trade · Traded Nov 24, 2025 · Filed Nov 25, 2025
Director purchased ~$1.7K of ANVS shares in the open marketSourceInsider trade · Traded Nov 21, 2025 · Filed Nov 22, 2025
Director purchased ~$35K of ANVS shares in the open marketSourceInsider trade · Traded Nov 21, 2025 · Filed Nov 22, 2025
Director purchased ~$35K of ANVS shares in the open marketSourceInsider trade · Traded Nov 14, 2025 · Filed Nov 18, 2025
Director purchased ~$32K of ANVS shares in the open marketSourceInsider trade · Traded Oct 28, 2025 · Filed Nov 12, 2025
Director purchased ~$2M of ANVS shares in the open marketSourceInsider trade · Traded Oct 28, 2025 · Filed Nov 12, 2025
CEO purchased ~$200K of ANVS shares in the open marketSource